On October 5, 2020, the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) proposed withdrawal of approval of Makena (hydroxyprogesterone caproate injection), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results